SYK vs. ABT, ISRG, BSX, MDT, BDX, EW, IDXX, RMD, DXCM, and STE
Should you be buying Stryker stock or one of its competitors? The main competitors of Stryker include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry.
Stryker vs. Its Competitors
Abbott Laboratories (NYSE:ABT) and Stryker (NYSE:SYK) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk, analyst recommendations and community ranking.
Abbott Laboratories has a net margin of 31.95% compared to Stryker's net margin of 13.25%. Stryker's return on equity of 23.58% beat Abbott Laboratories' return on equity.
Abbott Laboratories received 14 more outperform votes than Stryker when rated by MarketBeat users. Likewise, 70.00% of users gave Abbott Laboratories an outperform vote while only 64.42% of users gave Stryker an outperform vote.
Abbott Laboratories presently has a consensus price target of $142.59, indicating a potential upside of 5.72%. Stryker has a consensus price target of $427.30, indicating a potential upside of 12.14%. Given Stryker's higher possible upside, analysts plainly believe Stryker is more favorable than Abbott Laboratories.
Abbott Laboratories has higher revenue and earnings than Stryker. Abbott Laboratories is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.
75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 77.1% of Stryker shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by company insiders. Comparatively, 5.9% of Stryker shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Abbott Laboratories has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Comparatively, Stryker has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500.
In the previous week, Abbott Laboratories had 15 more articles in the media than Stryker. MarketBeat recorded 50 mentions for Abbott Laboratories and 35 mentions for Stryker. Stryker's average media sentiment score of 1.46 beat Abbott Laboratories' score of 1.17 indicating that Stryker is being referred to more favorably in the news media.
Abbott Laboratories pays an annual dividend of $2.36 per share and has a dividend yield of 1.7%. Stryker pays an annual dividend of $3.36 per share and has a dividend yield of 0.9%. Abbott Laboratories pays out 30.6% of its earnings in the form of a dividend. Stryker pays out 45.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Abbott Laboratories has increased its dividend for 54 consecutive years and Stryker has increased its dividend for 32 consecutive years. Abbott Laboratories is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Summary
Abbott Laboratories beats Stryker on 12 of the 22 factors compared between the two stocks.
Get Stryker News Delivered to You Automatically
Sign up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SYK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (NYSE:SYK) was last updated on 6/12/2025 by MarketBeat.com Staff
